We are proud to introduce Myelotracker®, a peptide-based probe. This unique technology specifically targets lactoferrin, a major protein stored in neutrophil granules, making it possible to visualize and study these immune cells with unmatched precision.
Unlike many existing tools, Myelotracker does not activate neutrophils, preserving their natural physiological state and ensuring reliable results. Its dual capability to detect intracellular granules in fixed samples and extracellular lactoferrin released during activation opeNeutrophil with Myelotrackerns new perspectives for exploring neutrophil biology.
Validated across multiple species including human, mouse, rabbit, and guinea pig, this versatile probe is compatible with tissue imaging, flow cytometry, in vitro assays, and experimental models of inflammation or infection.
With Myelotracker, Bertin Technologies expands its Bioreagent range with a powerful technology that bridges academic research and practical applications, giving scientists a new way to push forward the frontiers of immunology and inflammation research.
